$1.18 Billion in Sales Expected for Perrigo Company PLC (PRGO) This Quarter
Equities research analysts expect Perrigo Company PLC (NYSE:PRGO) to report sales of $1.18 billion for the current fiscal quarter, Zacks Investment Research reports. Twelve analysts have made estimates for Perrigo’s earnings. The lowest sales estimate is $1.16 billion and the highest is $1.19 billion. Perrigo reported sales of $1.28 billion during the same quarter last year, which would suggest a negative year-over-year growth rate of 7.8%. The company is scheduled to announce its next quarterly earnings report after the market closes on Wednesday, February 27th.
According to Zacks, analysts expect that Perrigo will report full-year sales of $4.72 billion for the current year, with estimates ranging from $4.69 billion to $4.73 billion. For the next year, analysts expect that the business will report sales of $4.77 billion, with estimates ranging from $4.58 billion to $4.90 billion. Zacks’ sales averages are an average based on a survey of research firms that that provide coverage for Perrigo.
A number of equities research analysts recently commented on the company. Royal Bank of Canada set a $50.00 target price on Perrigo and gave the stock a “hold” rating in a report on Friday, January 4th. Wells Fargo & Co set a $46.00 target price on Perrigo and gave the stock a “hold” rating in a report on Sunday, December 30th. Morgan Stanley set a $67.00 target price on Perrigo and gave the stock a “hold” rating in a report on Sunday, December 30th. Leerink Swann decreased their price target on Perrigo from $70.00 to $56.00 in a report on Monday, December 24th. Finally, Cantor Fitzgerald set a $107.00 price target on Perrigo and gave the company a “buy prgo” rating in a report on Thursday, December 20th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the company’s stock. Perrigo presently has a consensus rating of “Hold” and a consensus price target of $77.36.
Shares of Perrigo stock traded up $0.35 on Monday, reaching $48.95. 1,054,954 shares of the stock were exchanged, compared to its average volume of 1,527,917. The company has a quick ratio of 1.26, a current ratio of 1.85 and a debt-to-equity ratio of 0.54. Perrigo has a twelve month low of $36.28 and a twelve month high of $90.72. The company has a market capitalization of $6.65 billion, a price-to-earnings ratio of 9.93, a price-to-earnings-growth ratio of 1.78 and a beta of 1.31.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 19th. Investors of record on Friday, March 1st will be given a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a dividend yield of 1.55%. The ex-dividend date is Thursday, February 28th. Perrigo’s payout ratio is 15.42%.
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
Featured Article: What is a capital gain?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.